Purpose To compare results between standard and accelerated corneal collagen cross‐
linking (CXL) for the treatment of progressive keratoconus. Methods We performed literature …

Over the past 20 years, corneal crosslinking (CXL) has been used by surgeons to halt
progression in eyes with keratoconus. We reviewed the literature regarding the mechanism …

We compared one-year outcomes of conventional (3 mW/cm2, 365-nm ultraviolet-A light, 30
minutes) and accelerated (18 mW/cm2, 365-nm ultraviolet-A light, 5 minutes) collagen …

Corneal collagen crosslinking (CXL) is an approach used to increase the biomechanical
stability of the stromal tissue. Over the past 10 years, it has been used to halt the progression …

Purpose To assess effectiveness and safety of corneal crosslinking (CXL) to reduce
keratoconus (KC) progression and improve visual acuity among children with progressive …

Objectives To compare tear cytokine and chemokine levels of keratoconus (KC) patients
with controls to perceive etiology distinctly and to clarify the molecular changes after cross …

Keratoconus is a common pediatric corneal disease, leading to vision impairment and
amblyopia. Compared to its adult counterpart, pediatric keratoconus has an advanced …

Purpose: To assess intraoperative corneal pachymetry in patients undergoing accelerated
corneal collagen crosslinking with a dextran-free riboflavin solution. Methods: Prospective …

Purpose To evaluate corneal collagen crosslinking (CXL) with conventional and accelerated
ultraviolet-A (UVA) irradiation using riboflavin with methylcellulose. Setting Department of …

Purpose: To compare intraoperative changes in central corneal thickness (CCT) during
corneal cross-linking, using 2 different isotonic riboflavin solutions either with dextran or with …